![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
Stroke prevention |
Kidney Transplantation |
Free Subscription
1 Br J Clin Pharmacol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Kidney Transplantation is free of charge.
Volumetric microsampling for simultaneous remote immunosuppressant and kidney
function monitoring in outpatient kidney transplant recipients.
Br J Clin Pharmacol. 2022 Jun 7. doi: 10.1111/bcp.15433.
PubMed
Abstract available
The impact of mTOR inhibitors in the regression of left ventricular hypertrophy
in elderly kidney transplant recipients.
Clin Transplant. 2022 Jun 9:e14742. doi: 10.1111/ctr.14742.
PubMed
Abstract available
Second pregnancy following kidney transplantation is not associated with an
increased risk of graft loss in a single center retrospective cohort study.
Clin Transplant. 2022 Jun 7:e14741. doi: 10.1111/ctr.14741.
PubMed
Abstract available
Long term Tolerability and Clinical Outcomes associated with Tocilizumab in the
Treatment of Refractory Antibody Mediated Rejection (AMR) in Pediatric Renal
Transplant Recipients.
Clin Transplant. 2022 Jun 3:e14734. doi: 10.1111/ctr.14734.
PubMed
Abstract available
Precise clinicopathologic findings for application of genetic testing in
pediatric kidney transplant recipients with focal segmental
glomerulosclerosis/steroid-resistant nephrotic syndrome.
Pediatr Nephrol. 2022 Jun 2. pii: 10.1007/s00467-022-05604.
PubMed
Abstract available
Detection of infiltrating fibroblasts by single-cell transcriptomics in human
kidney allografts.
PLoS One. 2022;17:e0267704.
PubMed
Abstract available
Evolution of the Definition of Rejection in Kidney Transplantation and Its Use as
an Endpoint in Clinical Trials.
Transpl Int. 2022;35:10141.
PubMed
Abstract available
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New
Therapies for Kidney Transplantation.
Transpl Int. 2022;35:10137.
PubMed
Abstract available
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
Transpl Int. 2022;35:10139.
PubMed
Abstract available
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial
Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
Transpl Int. 2022;35:10135.
PubMed
Abstract available
Surrogate Endpoints for Late Kidney Transplantation Failure.
Transpl Int. 2022;35:10136.
PubMed
Abstract available
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial
Endpoint in Kidney Transplantation.
Transpl Int. 2022;35:10140.
PubMed
Abstract available
Alloimmune Risk Stratification for Kidney Transplant Rejection.
Transpl Int. 2022;35:10138.
PubMed
Abstract available
Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney
Transplantation Interventions.
Transpl Int. 2022;35:10134.
PubMed
Abstract available
Kidney Transplantation in Patients After Bariatric Surgery: High-Volume Bariatric
and Transplant Center Experience.
Transplant Proc. 2022 Jun 3. pii: S0041-1345(22)00292.
PubMed
Abstract available
Thank you for your interest in scientific medicine.
This policy is made possible thanks to
a media sponsorship by